{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-014821","form_type":"8-K","ticker":"AIXC","cik":"0001460702","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.497668+00:00","generated_at":"2026-06-03T22:11:56.656380+00:00","sec_items":["1.01","2.03","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Qualigen issues $1.1M convertible debenture & enters $1.5M co-development with Marizyme for DuraGraft","bullets":["Issued $1.1M 8% convertible debenture and warrant to Yi Hua Chen upon exercise of Alpha option for $1M cash.","Entered co-development agreement with Marizyme to fund commercial launch of FDA-cleared DuraGraft for CABG surgery.","Qualigen to provide up to $1.5M funding; receives share of Marizyme's gross profit on US sales capped at 2x return.","Exclusivity period until May 31, 2024 to negotiate broader strategic relationship with Marizyme.","DuraGraft addresses >500,000 CABG procedures annually in US; Qualigen gains participation in revenue generation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-014821","json":"https://secwatch.observer/filing/0001493152-24-014821.json","markdown":"https://secwatch.observer/filing/0001493152-24-014821.md","text":"https://secwatch.observer/filing/0001493152-24-014821.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224014821/0001493152-24-014821-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224014821/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T22:11:56.656380+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"aeae697f66f123c045aa6db870e75af100eb0bf5","claim":"AIxCrypto Holdings, Inc. incurred convertible notes of $1,100,000 with Yi Hua Chen at 8% per annum maturing December 31, 2024.","evidence_excerpt":"On April 12, 2024, against Chen’s Option exercise price of $1,000,000 paid to us, we delivered to Chen: - an 8% Convertible Debenture (the “Chen Debenture”) in the principal amount of $1,100,000, of like tenor as the Alpha Debenture except for the principal amount","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224014821/0001493152-24-014821-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$1,100,000"},{"label":"Counterparty","value":"Yi Hua Chen"},{"label":"Rate","value":"8% per annum"},{"label":"Maturity","value":"December 31, 2024"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}